Marianne Bjordal PhD, MBA
General Partner
Marianne joined 3B Future Health Fund in 2018 and was promoted to Partner in 2022. She has more than 15 years experience in research and early stage investment. Prior to joining 3B Future Health, Marianne worked as a researcher for the French National Centre for Scientific Research (CNRS). She is a former Marie Curie Early-Stage Researcher and was awarded the AXA Prize from the French Academy of Science in 2014.
Marianne received an M.Sc. in Molecular Biology from the University of Bergen in Norway, a Ph.D. in Molecular and Cellular Biology from the University of Nice in France and an MBA from the IAE Nice Graduate School of Management, France.
She is a former board member of Gain Therapeutics Inc [GANX] and currently serves on the board of NeoPhore Ltd, Epsilogen Ltd, Sibylla Biotech S.p.A. and GenEp Inc.
Our Team
Paolo Paoletti MD
Strategic Advisor
Alessandro Santoboni
Investment Analyst
Carlos von Bonhorst MD
Strategic Advisor
Riccardo Braglia MBA
Chairman and General Partner
Francesco Granata MD
Strategic Advisor and General Partner
Roberto De Ponti PharmD
Managing Director and General Partner
Francesco Giavatto MBA
Chief Financial Officer and General Partner
Karin Hehenberger MD, PhD
Strategic Advisor
Marianne Bjordal PhD, MBA
General Partner
Sandra van Essche JD
Corporate Affairs Advisor
Stefano Coco MSc
Associate
Get in touch
Thank you for your form submission, we will get in contact with you shortly.
